Document ID: chunk:federal_register_of_legislation:F2024L01521:clause:1_35
Version: federal_register_of_legislation:F2024L01521
Segment Type: clause
Provision Reference: sch 1 cl 35
Character Range: 22274–23409

35  Schedule 1 (table)
After:
Risperidone  Tablet 3 mg  Oral  Rispa  3 months stock by reference to usual demand

insert:
Rizatriptan   Tablet (orally disintegrating) 10 mg (as benzoate)  Oral  APO-RIZATRIPTAN ODT  4 months stock by reference to usual demand of both Rizatriptan ODT APOTEX and APO-RIZATRIPTAN ODT added together
Rosuvastatin  Tablet 10 mg (as calcium)                           Oral  APO-Rosuvastatin     6 months stock by reference to usual demand of both Rosuvastatin APOTEX and APO-Rosuvastatin added together
Rosuvastatin  Tablet 20 mg (as calcium)                           Oral  APO-ROSUVASTATIN     4 months stock by reference to usual demand of both Rosuvastatin APOTEX and APO-ROSUVASTATIN added together
Rosuvastatin  Tablet 40 mg (as calcium)                           Oral  APO-ROSUVASTATIN     4 months stock by reference to usual demand of both Rosuvastatin APOTEX and APO-ROSUVASTATIN added together
Rosuvastatin  Tablet 5 mg (as calcium)                            Oral  APO-ROSUVASTATIN     6 months stock by reference to usual demand of both Rosuvastatin APOTEX and APO-ROSUVASTATIN added together